■ 刊行論文
原著
|
1.
|
Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S†, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K:
. Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Ann Clin Transl Neurol. 2024 Apr 4.
Ann Clin Transl Neurol.
X
(doi: 10.1002/acn3.52051.)
:
, 2024
|
2.
|
Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S†, Nagane Y, Utsugisawa K.:
Taste disorders and alopecia in myasthenia gravis.
BMC Neurology
25
(24)
:139
-139
, 2024
|
3.
|
Konno S†*, Uchi T†, Kihara H†, Sugimoto H†.:
Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool.
Journal of the Neurological Sciences
460
(15)
:
, 2024
|
4.
|
Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S†. Kubota T, Samukawa M, Ishizuchi K, Tokuyasu D, Handa H, Yasuda M, Kawaguchi N, Kimura T, Suzuki Y, Sugimoto T, Minami N, Takahashi MP, Murai H, Utsugisawa K.:
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
Neurol Clin Pract.
14
(3)
:
, 2024
|
5.
|
Howard JF Jr, Bresch S, Farmakidis C, Freimer M, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Nowak RJ, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Bloemers J, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Vanderkelen M, Leite MI; RAISE-XT Study Team†:
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Ther Adv Neurol Disord.
17
(7562864241243186)
:
, 2024
|
|